Evidence map›Paper›PMID 34331326›Full record

ArticleActa paediatrica (Oslo, Norway : 1992)2021

Multi-inflammatory syndrome and Kawasaki disease in children during the COVID-19 pandemic: A nationwide register-based study and time series analysis.

Ulla Koskela, Otto Helve, Emmi Sarvikivi, Merja Helminen, Tea Nieminen, Ville Peltola, Marjo Renko, Harri Saxén, Hanna Pasma, Tytti Pokka and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Acta paediatrica (Oslo, Norway : 1992), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Ulla KoskelaDepartment of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.ORCID https://orcid.org/0000-0002-0812-8530
Otto HelveFinnish Institute for Health and Welfare, Helsinki, Finland.
Emmi SarvikiviFinnish Institute for Health and Welfare, Helsinki, Finland.
Merja HelminenDepartment of Pediatrics and Adolescent Medicine, Tampere University Hospital, Tampere, Finland.
Tea NieminenNew Children's Hospital, Helsinki University Hospital, Helsinki, Finland.
Ville PeltolaDepartment of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.
Marjo RenkoDepartment of Pediatrics and Adolescent Medicine, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland.
Harri SaxénNew Children's Hospital, Helsinki University Hospital, Helsinki, Finland.
Hanna PasmaDepartment of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.ORCID https://orcid.org/0000-0002-7956-2318
Tytti PokkaDepartment of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.
Minna HonkilaDepartment of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.
Terhi TapiainenDepartment of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.ORCID https://orcid.org/0000-0001-5433-4207
Oulu University Hospital · FIFinnish Institute for Health and Welfare · FIHelsinki University Hospital · FITampere University Hospital · FIUniversity of Eastern Finland · FIUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWe investigated whether the ongoing COVID-19 pandemic was associated with the occurrence of Kawasaki disease or with multi-inflammatory syndrome in children (MIS-C).

methodsThis national Finnish register-based study was based on laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, MIS-C and Kawasaki disease cases. We performed a time series analysis on the occurrence of Kawasaki disease in 2016-2020.

resultsIn 2020, there were 5170 laboratory-confirmed COVID-19 cases in children under 18 years of age and five fulfilled the MIS-C case definition. The occurrence of MIS-C was 0.97 per 1000 (95% confidence interval: 0.31-2.26) laboratory-confirmed SARS-CoV-2 infections in children. Our time series analysis showed that Kawasaki disease cases decreased during the COVID-19 pandemic. The seasonally adjusted incidence rate ratio was 0.49 (95% confidence interval: 0.32-0.74) when it was compared to pre-pandemic levels. This coincided with a reduced occurrence of respiratory infections, due to social distancing in the population.

conclusionThis nationwide register-based study found that MIS-C was a rare complication of the SARS-CoV-2 infection. The occurrence of Kawasaki disease and respiratory infections decreased during the pandemic. This suggests that transmissible microbes may play an important role in Kawasaki disease and social distancing may have a protective effect.

Indexed as

COVID-19Mucocutaneous Lymph Node SyndromeAdolescentChildFinlandHumansPandemicsSystemic Inflammatory Response SyndromeepidemiologyKawasaki diseasemulti-inflammatory syndrome in childrensocial distancingtransmissible microbes

Identifiers

PMID34331326
PMCPMC8444808
OpenAlexW3184705410

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.